This article was first published by The Times of Israel and is re-posted with permission.
Israeli scientists are harnessing the “destructive” qualities of allergy-causing cells, as part of a bold attempt to pioneer a new immunotherapy for fighting cancer.
A research team from Tel Aviv University has found that eosinophils, white blood cells that induce allergies, significantly reduce the growth of human tumors in vitro, and mouse tumors in the body.
SEE ALSO: Top 5 Recent Advances In Israeli Cancer Research and Treatment
Nine days after mice were injected with eosinophils, the overall size of tumors per mouse averaged half that of mice who weren’t injected.
To read the full article, click here.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Growing Bone From Your Own Tissue For ‘Seamless’ Healing
April 25, 2024
Femtech Firm Aims To Cure Endometriosis With Cannabinoids
April 07, 2024
Facebook comments